BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 33689097)

  • 1. A comprehensive analysis of tumor microenvironment-related genes in colon cancer.
    Luo R; Guo W; Wang H
    Clin Transl Oncol; 2021 Sep; 23(9):1769-1781. PubMed ID: 33689097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Construction of a Multi-Gene Risk Model for Colon Cancer Prognosis and Drug Treatments Prediction.
    Gao L; Tian Y; Chen E
    Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coordinating single-cell and bulk RNA-seq in deciphering the intratumoral immune landscape and prognostic stratification of prostate cancer patients.
    Sun Z; Wang J; Zhang Q; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Liu Y; Ye F; Ma B
    Environ Toxicol; 2024 Feb; 39(2):657-668. PubMed ID: 37565774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CAF-associated genes putatively representing distinct prognosis by in silico landscape of stromal components of colon cancer.
    Okuno K; Ikemura K; Okamoto R; Oki K; Watanabe A; Kuroda Y; Kidachi M; Fujino S; Nie Y; Higuchi T; Chuman M; Washio M; Sakuraya M; Niihara M; Kumagai K; Sangai T; Kumamoto Y; Naitoh T; Hiki N; Yamashita K
    PLoS One; 2024; 19(4):e0299827. PubMed ID: 38557819
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Immune-Related Analysis Based on Differentially Expressed Genes in Left- and Right-Sided Colon Adenocarcinoma.
    Guo JN; Li MQ; Deng SH; Chen C; Ni Y; Cui BB; Liu YL
    Front Oncol; 2021; 11():640196. PubMed ID: 33763372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Five Glycolysis-Related Gene Signature and Risk Score Model for Colorectal Cancer.
    Zhu J; Wang S; Bai H; Wang K; Hao J; Zhang J; Li J
    Front Oncol; 2021; 11():588811. PubMed ID: 33747908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Risk Model of Immune-Related Genes in Colorectal Cancer.
    Qian Y; Wei J; Lu W; Sun F; Hwang M; Jiang K; Fu D; Zhou X; Kong X; Zhu Y; Xiao Q; Hu Y; Ding K
    Front Genet; 2021; 12():619611. PubMed ID: 33747044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a prognostic signature based on immune-related genes in bladder cancer.
    Lv Z; Pang C; Wang J; Xia H; Liu J; Yan Q; Liu S; Liu M; Wang J
    Genomics; 2021 May; 113(3):1203-1218. PubMed ID: 33711453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a novel transcription factors-related prognostic signature for serous ovarian cancer.
    Li H; Wu N; Liu ZY; Chen YC; Cheng Q; Wang J
    Sci Rep; 2021 Mar; 11(1):7207. PubMed ID: 33785763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of alternative splicing signature in lung squamous cell carcinoma.
    Yan JQ; Liu M; Ma YL; Le KD; Dong B; Li GH
    Med Oncol; 2021 Mar; 38(5):49. PubMed ID: 33772655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Significance of a Novel Tumor Progression-Associated Immune Signature in Colorectal Adenocarcinoma.
    Mao R; Yang F; Wang Z; Xu C; Liu Q; Liu Y; Zhang T
    Front Cell Dev Biol; 2021; 9():625212. PubMed ID: 33732694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a five-immune gene model as an independent prognostic factor in hepatocellular carcinoma.
    Chen H; Li Y; Xiao SY; Guo J
    BMC Cancer; 2021 Mar; 21(1):278. PubMed ID: 33726698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic and Predictive Value of m6A "Eraser" Related Gene Signature in Gastric Cancer.
    Xu X; Zhou E; Zheng J; Zhang C; Zou Y; Lin J; Yu J
    Front Oncol; 2021; 11():631803. PubMed ID: 33718213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Weighted Gene Co-Expression Network Analysis-Derived Prognostic Model for Predicting Prognosis and Immune Infiltration in Gastric Cancer.
    Chen Q; Tan Y; Zhang C; Zhang Z; Pan S; An W; Xu H
    Front Oncol; 2021; 11():554779. PubMed ID: 33718128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients.
    Peng L; Li Y; Gu H; Xiang L; Xiong Y; Wang R; Zhou H; Wang J
    Aging (Albany NY); 2021 Mar; 13(6):9043-9055. PubMed ID: 33714943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune landscape during the tumorigenesis of cervical cancer.
    Wang Y; He M; Zhang G; Cao K; Yang M; Zhang H; Liu H
    Cancer Med; 2021 Apr; 10(7):2380-2395. PubMed ID: 33694292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma.
    Yan Q; Zheng W; Wang B; Ye B; Luo H; Yang X; Zhang P; Wang X
    BioData Min; 2021 May; 14(1):29. PubMed ID: 33962640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The low expression of NUP62CL indicates good prognosis and high level of immune infiltration in lung adenocarcinoma.
    Ren S; Wang W; Zhang C; Sun Y; Sun M; Wang Y; Zhang X; Lu B; Yao L
    Cancer Med; 2021 May; 10(10):3403-3412. PubMed ID: 33934535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a five-gene signature of the RGS gene family with prognostic value in ovarian cancer.
    Hu Y; Zheng M; Wang S; Gao L; Gou R; Liu O; Dong H; Li X; Lin B
    Genomics; 2021 Jul; 113(4):2134-2144. PubMed ID: 33845140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comprehensive Analysis of Ferroptosis Regulators in Lung Adenocarcinomas Identifies Prognostic and Immunotherapy-Related Biomarkers.
    Sun S; Guo W; Lv F; Zhang G; Wang J; Li R; Tan F; Li N; Xue Q; Gao Y; Gao S; He J
    Front Mol Biosci; 2021; 8():587436. PubMed ID: 33778001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.